Cigna to Report Q2 Earnings: Can Evernorth Offset Healthcare Weakness?

Core Insights - The Cigna Group is expected to report second-quarter 2025 results on July 31, 2025, with earnings estimated at $7.14 per share and revenues of $62.69 billion, reflecting a year-over-year increase of 6.3% in earnings and 3.7% in revenues [1][2][7] Financial Performance Estimates - The full-year 2025 revenue estimate for Cigna is $258.19 billion, indicating a 4.5% year-over-year growth, while the EPS consensus for 2025 is $29.68, signaling an 8.6% increase year-over-year [3] - Cigna has beaten earnings estimates in three of the last four quarters, with an average surprise of negative 0.3% [3] Earnings Prediction Model - The current model does not predict an earnings beat for Cigna, with an Earnings ESP of -0.54% and a Zacks Rank of 3 (Hold) [4] Revenue Breakdown - Evernorth revenues are projected to grow by 9.9%, while Cigna Healthcare revenues are expected to decline by 18.3% [7] - Pharmacy revenues are estimated to improve by 9%, and fees and other revenues are expected to grow by 11% year-over-year [8] - The overall Evernorth Health Services segment is projected to generate $54.4 billion in revenues, reflecting a 9.9% growth from the prior year [8] Customer and Investment Income Trends - The total medical customers for Cigna are estimated at 17.9 million, down from 19 million a year ago [10] - The consensus estimate for net investment income suggests a significant decline of 31.5% year-over-year [10] Margin and Cost Pressures - The medical care ratio is expected to rise to 83.15%, indicating margin pressure due to elevated medical costs and other expenses [11]